BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Condition:   Metastatic Colorectal Carcinoma Interventions:   Drug: Encorafenib;   Drug: Cetuximab Sponsors:   Pierre Fabre Pharma GmbH;   iOMEDICO AG;   Pierre Fabre Pharma AG;   Pierre Fabre Pharma Austria Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2020 Category: Research Source Type: clinical trials